SCHEMBL4890220

SCHEMBL4890220

CC(C)CN(CCCCN(Cc1ccc(C(=O)NNc2ccccc2)cc1)Cc1ncc[nH]1)CC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 4/20 0.42
HDAC1 Q13547 3/20 0.41
HDAC6 Q9UBN7 3/20 0.41
TAAR1 Q96RJ0 2/20 0.38
OPRK1 P41145 1/20 0.38
PTGS2 P35354 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
GAA P10253 4/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC2 Q92769 2/20 0.37
HTT P42858 2/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748136 0.88 CXCR4 (0.42) CXCR4HDAC1HDAC6TAAR1PTGS2
SCHEMBL14005295 0.85 HDAC1 (0.46) HDAC1HDAC6OPRK1PTGS2SMN1; SMN2
SCHEMBL14004916 0.82 CXCR4 (0.42) CXCR4HDAC1HDAC6ALDH1A1KDM4E
SCHEMBL1206171 0.82 CXCR4 (0.49) CXCR4OPRK1SMN1; SMN2ALDH1A1
SCHEMBL14005308 0.79 HDAC1 (0.44) CXCR4HDAC1HDAC6TAAR1OPRK1
SCHEMBL14005298 0.77 PTGS2 (0.44) HDAC1HDAC6OPRK1PTGS2SMN1; SMN2
SCHEMBL13078625 0.76 CXCR4 (0.44) CXCR4OPRK1ALDH1A1
SCHEMBL1205357 0.76 CXCR4 (0.51) CXCR4OPRK1ALDH1A1HTT
SCHEMBL4893797 0.75 CXCR4 (0.55) CXCR4HDAC1HDAC6TAAR1OPRK1
SCHEMBL14005311 0.74 CXCR4 (0.51) CXCR4HDAC1HDAC6TAAR1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293711-A1 Chemokine receptor modulators METASTATIX, INC. 2008-11-27 US disclosed
US-20080293711-A1 Chemokine receptor modulators METASTATIX, INC. 2008-11-27 US disclosed
US-20080293711-A1 Chemokine receptor modulators METASTATIX, INC. 2008-11-27 US disclosed
WO-2008112156-A1 CHEMOKINE RECEPTOR MODULATORS ALTIRIS THERAPEUTICS (US) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293711-A1 Chemokine receptor modulators CCR5, CCL2, CXCR4 CXCR4 3/4885HDAC1 803/4885HDAC6 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.